- -

COVID-19 Healthcare Planning: Predicting Mortality and the Role of the Herd Immunity Barrier in the General Population

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

  • Estadisticas de Uso

COVID-19 Healthcare Planning: Predicting Mortality and the Role of the Herd Immunity Barrier in the General Population

Mostrar el registro sencillo del ítem

Ficheros en el ítem

Thumbnail
Nombre: Marco-Franco;Guad ...
Tamaño: 748.1Kb
Formato: PDF
Descripción: Versión editorial
Abrir
dc.contributor.author Marco-Franco, Julio Emilio es_ES
dc.contributor.author Guadalajara Olmeda, María Natividad es_ES
dc.contributor.author González-De Julián, Silvia es_ES
dc.contributor.author Vivas-Consuelo, David es_ES
dc.date.accessioned 2021-05-22T03:31:28Z
dc.date.available 2021-05-22T03:31:28Z
dc.date.issued 2020-07 es_ES
dc.identifier.uri http://hdl.handle.net/10251/166637
dc.description.abstract [EN] Using a mathematical model for COVID-19 incorporating data on excess of mortality compared to the corresponding period of the previous year obtained from the daily monitoring of mortality in Spain (MoMo), the prediction of total number of casualties in Spain for the first outbreak has been computed. From this figure, and following a stepwise meta-analysis of available reports, the case fatality rate (CFR) and the infectious case fatality rate (IFR) for the outbreak have been estimated. As the impact of age on these rates is notable, it is proposed to include an age-related adjusted fatality ratio in future comparative analyses between studies, calculated by adjusting the results by risk ratio to a reference age band (e.g., 60-69). From the casualty figures, and the corresponding CFR and IFR ratios, the forecast of serologically positive cases in the general Spanish population has been estimated at approximately 1% (0.87-1.3%) of the samples. If the data are confirmed by the ongoing study of the Carlos III Institute, until a vaccine is found, the immunity acquired in the general population after the infectious outbreak is far from the 65-70% herd immunity required as a barrier for COVID-19. es_ES
dc.language Inglés es_ES
dc.publisher MDPI AG es_ES
dc.relation.ispartof Sustainability es_ES
dc.rights Reconocimiento (by) es_ES
dc.subject Healthcare planning es_ES
dc.subject Health economy es_ES
dc.subject Herd immunity es_ES
dc.subject Mathematical epidemiology es_ES
dc.subject COVID-19 es_ES
dc.subject Case fatality rate es_ES
dc.subject Infectious fatality rate es_ES
dc.subject Relative risk ratio es_ES
dc.subject Predictive modeling es_ES
dc.subject.classification ECONOMIA APLICADA es_ES
dc.subject.classification ECONOMIA FINANCIERA Y CONTABILIDAD es_ES
dc.subject.classification ECONOMIA, SOCIOLOGIA Y POLITICA AGRARIA es_ES
dc.title COVID-19 Healthcare Planning: Predicting Mortality and the Role of the Herd Immunity Barrier in the General Population es_ES
dc.type Artículo es_ES
dc.identifier.doi 10.3390/su12135228 es_ES
dc.rights.accessRights Abierto es_ES
dc.contributor.affiliation Universitat Politècnica de València. Departamento de Economía y Ciencias Sociales - Departament d'Economia i Ciències Socials es_ES
dc.description.bibliographicCitation Marco-Franco, JE.; Guadalajara Olmeda, MN.; González-De Julián, S.; Vivas-Consuelo, D. (2020). COVID-19 Healthcare Planning: Predicting Mortality and the Role of the Herd Immunity Barrier in the General Population. Sustainability. 12(13):1-10. https://doi.org/10.3390/su12135228 es_ES
dc.description.accrualMethod S es_ES
dc.relation.publisherversion https://doi.org/10.3390/su12135228 es_ES
dc.description.upvformatpinicio 1 es_ES
dc.description.upvformatpfin 10 es_ES
dc.type.version info:eu-repo/semantics/publishedVersion es_ES
dc.description.volume 12 es_ES
dc.description.issue 13 es_ES
dc.identifier.eissn 2071-1050 es_ES
dc.relation.pasarela S\414740 es_ES
dc.description.references Mathematical modeling draws more accurate picture of coronavirus cases 2020https://www.eurekalert.org/pub_releases/2020-04/mcog-mmd041020.php es_ES
dc.description.references Red Nacional de Vigilancia Epidemiológica-[Spanish epidemiological surveillance network]https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/INFORMES/Informes%20COVID-19/Informe%20nº%2022.%20Situación%20de%20COVID-19%20en%20España%20a%2013%20de%20abril%20de%202020.pdf es_ES
dc.description.references Jung, S., Akhmetzhanov, A. R., Hayashi, K., Linton, N. M., Yang, Y., Yuan, B., … Nishiura, H. (2020). Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases. Journal of Clinical Medicine, 9(2), 523. doi:10.3390/jcm9020523 es_ES
dc.description.references Linton, N., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A., Jung, S., … Nishiura, H. (2020). Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data. Journal of Clinical Medicine, 9(2), 538. doi:10.3390/jcm9020538 es_ES
dc.description.references Rajgor, D. D., Lee, M. H., Archuleta, S., Bagdasarian, N., & Quek, S. C. (2020). The many estimates of the COVID-19 case fatality rate. The Lancet Infectious Diseases, 20(7), 776-777. doi:10.1016/s1473-3099(20)30244-9 es_ES
dc.description.references Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020). Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Eurosurveillance, 25(10). doi:10.2807/1560-7917.es.2020.25.10.2000180 es_ES
dc.description.references Wu, J. T., Leung, K., Bushman, M., Kishore, N., Niehus, R., de Salazar, P. M., … Leung, G. M. (2020). Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature Medicine, 26(4), 506-510. doi:10.1038/s41591-020-0822-7 es_ES
dc.description.references Hauser, A., Counotte, M. J., Margossian, C. C., Konstantinoudis, G., Low, N., Althaus, C. L., & Riou, J. (2020). Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: a modeling study in Hubei, China, and six regions in Europe. doi:10.1101/2020.03.04.20031104 es_ES
dc.description.references Russell, T. W., Hellewell, J., Jarvis, C. I., van Zandvoort, K., Abbott, S., … Ratnayake, R. (2020). Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Eurosurveillance, 25(12). doi:10.2807/1560-7917.es.2020.25.12.2000256 es_ES
dc.description.references Wu, Z., & McGoogan, J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA, 323(13), 1239. doi:10.1001/jama.2020.2648 es_ES
dc.description.references Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet, 395(10223), 507-513. doi:10.1016/s0140-6736(20)30211-7 es_ES
dc.description.references Wang, X., Ma, Z., Ning, Y., Chen, C., Chen, R., Chen, Q., … Zhao, H. (2020). Estimating the case fatality ratio of the COVID-19 epidemic in China. doi:10.1101/2020.02.17.20023630 es_ES
dc.description.references Italian Task Force COVID-19. Epidemia COVID-19 [Covid-19 epidemic]https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_26-marzo%202020.pdf es_ES
dc.description.references UK coronavirus death toll reaches 1,789 amid data reporting concerns |World news| The Guardianhttps://www.theguardian.com/world/2020/mar/31/uk-coronavirus-death-toll-reaches-1789-amid-data-reporting-concerns es_ES
dc.description.references Coronavirus-missing-deathshttps://www.nytimes.com/interactive/2020/04/21/world/coronavirus-missing-deaths.html es_ES
dc.description.references Lipsitch, M., Cohen, T., Cooper, B., Robins, J. M., Ma, S., James, L., … Murray, M. (2003). Transmission Dynamics and Control of Severe Acute Respiratory Syndrome. Science, 300(5627), 1966-1970. doi:10.1126/science.1086616 es_ES
dc.description.references Sanche, S., Lin, Y. T., Xu, C., Romero-Severson, E., Hengartner, N., & Ke, R. (2020). High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerging Infectious Diseases, 26(7), 1470-1477. doi:10.3201/eid2607.200282 es_ES
dc.description.references WHO warns that few have developed antibodies to Covid-19https://www.theguardian.com/society/2020/apr/20/studies-suggest-very-few-have-had-covid-19-without-symptoms es_ES
dc.description.references Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., … Ferguson, N. M. (2020). Estimates of the severity of COVID-19 disease. doi:10.1101/2020.03.09.20033357 es_ES
dc.description.references Wong, J. Y., Kelly, H., Ip, D. K. M., Wu, J. T., Leung, G. M., & Cowling, B. J. (2013). Case Fatality Risk of Influenza A (H1N1pdm09). Epidemiology, 24(6), 830-841. doi:10.1097/ede.0b013e3182a67448 es_ES
dc.description.references Bendavid, E., Mulaney, B., Sood, N., Shah, S., Ling, E., Bromley-Dulfano, R., … Bhattacharya, J. (2020). COVID-19 Antibody Seroprevalence in Santa Clara County, California. doi:10.1101/2020.04.14.20062463 es_ES
dc.subject.ods 03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edades es_ES


Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem